Valence ロゴ
人気
ログイン
Loading data for OGN — first visit, this takes a few seconds.

ウォッチリストに追加

Organon & Co.

NYSE: OGN · リアルタイム株価 · USD
13.70
-0.02 (-0.15%)
終値時点： Aug 17, 2026, 8:00 PM

Organon & Co. (OGN) Stock Price, Analysis & Data

-0.15%

データがありません

買気配n/a
時価総額3.6B
売上高（TTM）6.13B
純利益（TTM）209M
ベータ1.52
EPS（TTM）0.78
PER（TTM）17.56
予想PER3.77
PBR（TTM）3.58
PSR（TTM）0.59
Earnings DateNov 9, 2026
売気配n/a
出来高1,702,121
平均出来高（20日）2,615,227
始値13.71
前日終値13.72
当日レンジ13.69 - 13.72
52週レンジ5.69 - 13.72
アナリストn/a
目標株価n/a
配当$0.08 (0.58%)
権利落ち日2026年8月14日

OGNについて

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; C...

[続きを読む]
業種 Drug Manufacturers - General
セクター Healthcare
IPO日 May 14, 2021
従業員数 10,000
上場取引所 NYSE
ティッカー OGN
ウェブサイト https://www.organon.com
企業情報の全文

業績

2025年のOrganon &の売上高は6.22Bで、前年の6.4Bから-2.92%の減少でした。 利益は187Mで、-78.36%の減少でした。

財務諸表

決算サプライズ

Organon &はJul 31, 2026に四半期決算を発表しました：
  • 売上高は $1.56B で、予想を下回りました $0, うち -2.26% の前年比減少.
  • EPSは 0.85 で、予想を下回りました -0.22, うち -15.00% の前年比減少.

    • 次回決算発表

    Organon & Co.の決算発表予定日は Nov 9, 2026, 寄り付き前の予定です。
    アナリストの売上高予想は ... アップグレード
    news image

    2週間前 · Zacks

    Compared to Estimates, Organon (OGN) Q2 Earnings: A Look at Key Metrics

    Although the revenue and EPS for Organon (OGN) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street es...

    news image

    2週間前 · Zacks

    Organon (OGN) Lags Q2 Earnings Estimates

    Organon (OGN) delivered earnings and revenue surprises of -2.30% and +1.09%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

    news image

    2週間前 · Reuters

    Sun Pharma's quarterly profit jumps on strength in specialty medicines

    By Kashish Tandon July 31 (Reuters) - India's Sun Pharmaceutical Industries reported a 27% rise in first-quarter profit on Friday, driven by robust growth in its high-margin specialty medicines

    news image

    3週間前 · Zacks

    Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

    Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

    news image

    3週間前 · MarketBeat

    Organon & Co. Shareholders Clear Sun Pharma Merger Deal

    Shareholders of Organon & Co. (NYSE:OGN) approved the company’s proposed merger agreement with Sun Pharmaceutical Holdings USA, Inc. at a virtual special meeting held Wednesday, according to prelimina...

    2ページ中1ページ